Revised SPC: Betamethasone dipropionate and calcipotriol (Enstilar) cutaneous foam
Update includes deletion of warning regarding UV exposure in section 4.4, deletion of statement regarding photocarcinogenicity studies in section 5.3, rewording of statement regarding dermal carcinogenicity studies and additional description of foam appearance.
Source:
electronic Medicines compendium